Bearish
Earnings call transcript: Puma Biotech Q1 2026 misses EPS, revenue forecasts
Puma Biotechnology Inc. (PBYI) reported a net loss per share of -$0.04 for Q1 2026, missing analyst expectations of $0.00, and revenue of $44.8 millio...